Company news

Avacta Group PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Notice of Results

May 15, 2025

Investor Webinar

May 12, 2025

Block Listing Application to AIM

May 8, 2025

Board change

April 29, 2025

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

April 28, 2025

Avacta presents preclinical data at AACR

April 28, 2025

Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting

April 28, 2025

Avacta presents data from lead candidate at AACR

April 28, 2025

Issue of Equity and Total Voting Rights

April 23, 2025

Avacta Quarterly Update

March 31, 2025

Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives

March 31, 2025

Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting

March 26, 2025

Avacta Announces Presentations at AACR

March 26, 2025

Avacta Completes Launch Diagnostics Sale

March 25, 2025

Avacta to Present at Leerink Healthcare Conference

March 10, 2025

Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference

March 10, 2025

Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts

March 7, 2025

Avacta announces data update for AVA6000

March 7, 2025

Avacta to sell Launch Diagnostics

March 7, 2025

Appointment of Joint Broker

February 4, 2025

Avacta Announces Data from AVA6000 Phase 1 trial

January 16, 2025

Avacta Appoints Chief Financial Officer

January 13, 2025

Completion of Dose Escalation and RDE Arms

December 12, 2024

R&D Spotlight focusing on pipeline advances

October 30, 2024

Avacta Reports Pipeline Avances at EORTC

October 24, 2024

Avacta and Tempus Enter Strategic Collaboration

October 21, 2024

Avacta Expands its Pipeline

October 17, 2024

Avacta appoints Chief Scientific Officer

October 15, 2024

Avacta Group strengthens executive team with...

October 15, 2024

Avacta Unveils Pipeline Expansion at EORTC 2024

October 10, 2024

Avacta to Unveil Pipeline Expansion and Novel...

October 10, 2024

Interim Results

September 30, 2024

Avacta Reported Updated Phase 1 Data of AVA6000

September 16, 2024

Avacta Reports Updated Phase 1 Clinical Data...

September 14, 2024

Avacta to present clinical data at ESMO Congress

September 9, 2024

Avacta to present updated clinical data on AV...

September 8, 2024

Director/PDMR Shareholdings and TVR

September 2, 2024

Convertible Bond Payment

July 18, 2024

AGM Business Update

June 26, 2024

Shaun Chilton appointed Non-Executive Chairman

June 20, 2024

Appointment of Nominated Adviser and Sole Broker

June 11, 2024

Posting of Annual Report and Notice of AGM

May 31, 2024

Successful Completion of First Cohort

May 23, 2024

Full Year Results

April 30, 2024

Board Change

April 30, 2024

Block listing Interim Return REPLACEMENT

April 26, 2024

Avacta Reports Data at the AACR Annual Meeting

April 9, 2024

AVA6000 Abstract Release by AACR

April 8, 2024

Avacta Group - AVA6000 Abstract Release by AA...

April 5, 2024

Update on AVA6000 Phase 1a Clinical Trial Progress

March 21, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.